Brussels, 03/09/2015 (Agence Europe) - A new report released on Wednesday 2 September by the Corporate Europe Observatory (CEO) reveals the dramatic extent of the pharmaceutical industry's lobbying efforts towards EU decision-makers, with the industry spending an estimated 15 times more than civil society actors working on public health or access to medicine.
In the Policy prescriptions: the firepower of the EU pharmaceutical lobby and implications for public health report, CEO probes the...